Stock Events

Elekta AB 

$6.54
21
-$0.07-0.98% Wednesday 19:31

Statistics

Day High
6.87
Day Low
6.87
52W High
8.62
52W Low
5.86
Volume
499
Avg. Volume
6,371
Mkt Cap
2.62B
P/E Ratio
23.38
Dividend Yield
3.54%
Dividend
0.23

Upcoming

Dividends

3.54%Dividend Yield
10Y Growth
0.91%
5Y Growth
6.78%
3Y Growth
29.45%
1Y Growth
3.82%

Earnings

27NovExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2023
Q1 2024
Q2 2024
Next
0.03
0.38
0.74
1.09
Expected EPS
0.079464
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EKTAY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap113.61B
Medtronic competes with Elekta in the neurosurgical market, offering products for brain surgeries and pain management that overlap with Elekta's Gamma Knife radiosurgery systems.
Intuitive Surgical
ISRG
Mkt Cap175.06B
Intuitive Surgical competes in the surgical space with robotic systems that, while not directly radiation therapy, offer alternative treatments for conditions Elekta's products also address.
Boston Scientific
BSX
Mkt Cap120.45B
Boston Scientific competes in the medical device market, particularly in neuromodulation, where its products can be seen as alternatives to Elekta's for certain conditions.
Smith & Nephew
SNN
Mkt Cap13.45B
Smith & Nephew competes in the advanced wound management and surgical devices market, indirectly competing with Elekta's offerings in surgical and oncology care.
Zimmer Biomet
ZBH
Mkt Cap23.51B
Zimmer Biomet competes in the musculoskeletal healthcare market, including surgical solutions that can indirectly compete with Elekta's products for certain therapeutic and diagnostic applications.
Stryker
SYK
Mkt Cap137.35B
Stryker competes across several medical device markets, including neurotechnology and spine, where its products can compete with Elekta's neurosurgical and radiosurgery offerings.
Globus Medical
GMED
Mkt Cap9.84B
Globus Medical competes in the spine and neurosurgery markets with products that can be alternatives to Elekta's solutions for spinal and brain conditions.
Abbvie
ABBV
Mkt Cap346.75B
AbbVie, through its acquisition of Allergan, competes in the neuroscience space, offering pharmaceutical alternatives to Elekta's device-based treatments for neurological conditions.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson, through its medical devices division, competes in several areas including surgery and oncology, offering products that can be seen as alternatives to Elekta's radiation therapy and neurosurgery devices.

About

Medical Specialties
Health Technology
Manufacturing
Surgical and Medical Instrument Manufacturing
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
Show more...
CEO
Gustaf Salford
Employees
4584
Country
US
ISIN
US28617Y1010

Listings